To Vaccinate or Not: Impact of Bovine Viral Diarrhoea in French Cow-Calf Herds

Vaccines (Basel). 2021 Oct 6;9(10):1137. doi: 10.3390/vaccines9101137.

Abstract

Bovine viral diarrhoea (BVD) remains an issue despite control programs implemented worldwide. Virus introduction can occur through contacts with neighbouring herds. Vaccination can locally protect exposed herds. However, virus spread depends on herd characteristics, which may impair vaccination efficiency. Using a within-herd epidemiological model, we compared three French cow-calf farming systems named by their main breed: Charolaise, Limousine, and Blonde d'Aquitaine. We assessed vaccination strategies of breeding females assuming two possible protections: against infection or against vertical transmission. Four commercial vaccines were considered: Bovilis®, Bovela®, Rispoval®, and Mucosiffa®. We tested various virus introduction frequency in a naïve herd. We calculated BVD economic impact and vaccination reward. In Charolaise, BVD economic impact was 113€ per cow over 5 years after virus introduction. Irrespective of the vaccine and for a high enough risk of introduction, the yearly expected reward was 0.80€ per invested euro per cow. Vaccination should not be stopped before herd exposure has been decreased. In contrast, the reward was almost nil in Blonde d'Aquitaine and Limousine. This highlights the importance of accounting for herd specificities to assess BVD impact and vaccination efficiency. To guide farmers' vaccination decisions against BVD, we transformed this model into a French decision support tool.

Keywords: BVD; cattle; control strategy; economic impact; endemic disease; epidemiology; model; vaccination.